Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients

E. A. Ermakov, S. A. Ivanova, V. N. Buneva, G. A. Nevinsky

Результат исследований: Материалы для журналаСтатья

1 цитирование (Scopus)

Выдержка

Abzymes with various catalytic activities are the earliest statistically significant markers of existing and developing autoimmune diseases (AIDs). Currently, schizophrenia (SCZD) is not considered to be a typical AID. It was demonstrated recently that antibodies from SCZD patients efficiently hydrolyze DNA and myelin basic protein. Here, we showed for the first time that autoantibodies from 35 SCZD patients efficiently hydrolyze RNA (cCMP > poly(C) > poly(A) > yeast RNA) and analyzed site-specific hydrolysis of microRNAs involved in the regulation of several genes in SCZD (miR-137, miR-9-5p, miR-219-2-3p, and miR-219a-5p). All four microRNAs were cleaved by IgG preparations (n = 21) from SCZD patients in a site-specific manner. The RNase activity of the abzymes correlated with SCZD clinical parameters. The data obtained showed that SCZD patients might display signs of typical autoimmune processes associated with impaired functioning of microRNAs resulting from their hydrolysis by the abzymes.

Язык оригиналаАнглийский
Страницы (с-по)507-526
Число страниц20
ЖурналBiochemistry (Moscow)
Том83
Номер выпуска5
DOI
СостояниеОпубликовано - 1 мая 2018
Опубликовано для внешнего пользованияДа

Отпечаток

MicroRNAs
Schizophrenia
Blood
Immunoglobulin G
RNA
Antibodies
Hydrolysis
Autoimmune Diseases
Poly C
Poly A
Myelin Basic Protein
Ribonucleases
Autoantibodies
Yeast
Catalyst activity
Genes
Yeasts
DNA

ASJC Scopus subject areas

  • Biochemistry

Цитировать

Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients. / Ermakov, E. A.; Ivanova, S. A.; Buneva, V. N.; Nevinsky, G. A.

В: Biochemistry (Moscow), Том 83, № 5, 01.05.2018, стр. 507-526.

Результат исследований: Материалы для журналаСтатья

Ermakov, E. A. ; Ivanova, S. A. ; Buneva, V. N. ; Nevinsky, G. A. / Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients. В: Biochemistry (Moscow). 2018 ; Том 83, № 5. стр. 507-526.
@article{2900e9f0381c4fa092ce2687f9ee36fc,
title = "Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients",
abstract = "Abzymes with various catalytic activities are the earliest statistically significant markers of existing and developing autoimmune diseases (AIDs). Currently, schizophrenia (SCZD) is not considered to be a typical AID. It was demonstrated recently that antibodies from SCZD patients efficiently hydrolyze DNA and myelin basic protein. Here, we showed for the first time that autoantibodies from 35 SCZD patients efficiently hydrolyze RNA (cCMP > poly(C) > poly(A) > yeast RNA) and analyzed site-specific hydrolysis of microRNAs involved in the regulation of several genes in SCZD (miR-137, miR-9-5p, miR-219-2-3p, and miR-219a-5p). All four microRNAs were cleaved by IgG preparations (n = 21) from SCZD patients in a site-specific manner. The RNase activity of the abzymes correlated with SCZD clinical parameters. The data obtained showed that SCZD patients might display signs of typical autoimmune processes associated with impaired functioning of microRNAs resulting from their hydrolysis by the abzymes.",
keywords = "abzymes, miRNA hydrolysis, polyribonucleotide, schizophrenia patients",
author = "Ermakov, {E. A.} and Ivanova, {S. A.} and Buneva, {V. N.} and Nevinsky, {G. A.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1134/S0006297918050048",
language = "English",
volume = "83",
pages = "507--526",
journal = "Biochemistry. Biokhimiia",
issn = "0006-2979",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "5",

}

TY - JOUR

T1 - Blood-Derived RNA- and microRNA-Hydrolyzing IgG Antibodies in Schizophrenia Patients

AU - Ermakov, E. A.

AU - Ivanova, S. A.

AU - Buneva, V. N.

AU - Nevinsky, G. A.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Abzymes with various catalytic activities are the earliest statistically significant markers of existing and developing autoimmune diseases (AIDs). Currently, schizophrenia (SCZD) is not considered to be a typical AID. It was demonstrated recently that antibodies from SCZD patients efficiently hydrolyze DNA and myelin basic protein. Here, we showed for the first time that autoantibodies from 35 SCZD patients efficiently hydrolyze RNA (cCMP > poly(C) > poly(A) > yeast RNA) and analyzed site-specific hydrolysis of microRNAs involved in the regulation of several genes in SCZD (miR-137, miR-9-5p, miR-219-2-3p, and miR-219a-5p). All four microRNAs were cleaved by IgG preparations (n = 21) from SCZD patients in a site-specific manner. The RNase activity of the abzymes correlated with SCZD clinical parameters. The data obtained showed that SCZD patients might display signs of typical autoimmune processes associated with impaired functioning of microRNAs resulting from their hydrolysis by the abzymes.

AB - Abzymes with various catalytic activities are the earliest statistically significant markers of existing and developing autoimmune diseases (AIDs). Currently, schizophrenia (SCZD) is not considered to be a typical AID. It was demonstrated recently that antibodies from SCZD patients efficiently hydrolyze DNA and myelin basic protein. Here, we showed for the first time that autoantibodies from 35 SCZD patients efficiently hydrolyze RNA (cCMP > poly(C) > poly(A) > yeast RNA) and analyzed site-specific hydrolysis of microRNAs involved in the regulation of several genes in SCZD (miR-137, miR-9-5p, miR-219-2-3p, and miR-219a-5p). All four microRNAs were cleaved by IgG preparations (n = 21) from SCZD patients in a site-specific manner. The RNase activity of the abzymes correlated with SCZD clinical parameters. The data obtained showed that SCZD patients might display signs of typical autoimmune processes associated with impaired functioning of microRNAs resulting from their hydrolysis by the abzymes.

KW - abzymes

KW - miRNA hydrolysis

KW - polyribonucleotide

KW - schizophrenia patients

UR - http://www.scopus.com/inward/record.url?scp=85047263657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047263657&partnerID=8YFLogxK

U2 - 10.1134/S0006297918050048

DO - 10.1134/S0006297918050048

M3 - Article

C2 - 29738685

AN - SCOPUS:85047263657

VL - 83

SP - 507

EP - 526

JO - Biochemistry. Biokhimiia

JF - Biochemistry. Biokhimiia

SN - 0006-2979

IS - 5

ER -